OBAMA APPOINTS GHANAIAN TO SERVE BOARD (OLD NAVASCAN) !!!

14 Dec 2016 no comments Folio 14794

A Ghanaian professor of Surgery and Pathology based in the United States of America (USA) has been appointed by President Barack Obama to serve on the US National Cancer Advisory Board.

Dr Francis Ali-Osman was appointed among other members to advise President Obama, the US Secretary of Health and Human Service and the Director of the National Cancer Institute on a wide range of issues relating to the US national cancer programme.
The world-renowned cancer researcher and oncology leader is currently the distinguished Professor of Neuro-Oncology Research at the Duke University School of Medicine in the USA.

In an interview during a visit to the head office of the Graphic Communications Group Limited, Dr Ali-Osman said: “It is a great honour because very few people are privileged to have this opportunity.”
He said his appointment also demonstrated Ghana’s human resource potential.

Academic background
From the Navrongo Senior High School in the Upper East Region through to the Kwame Nkrumah University of Science and Technology where he had his undergraduate training in Pharmacy, Dr Ali-Osman moved to obtain advanced doctorate degrees in Germany.
He pursued doctorate degrees in Biochemistry/Molecular Biology, Pharmacology and Laboratory Medicine from the Free University of Berlin, Germany, and completed a fellowship programme in Neuro-oncology at the Brain Tumour Research Center at the School of Medicine of the University of California, San Francisco.

In the US, Dr Ali-Osman has served in a variety of positions, including Assistant Professor and Director of Brain Tumour Research at the University of Washington School of Medicine and Senior Investigator and Chief Scientific Officer at the Hipple Cancer Research Centre at the Wright State University School of Medicine.

Also, he has been the Associate Professor and Chairman of the Department of Experimental Pediatrics and Professor and Director of Neurosurgery Research at the University of Texas MD Anderson Cancer Center